HuGE Literature Finder
Records
1
-
5
Response Stratification in the First-Line Combined Immunotherapy of Hepatocellular Carcinoma at Genomic, Transcriptional and Immune Repertoire Levels. Journal of hepatocellular carcinoma 2021 8 1281-1295. Cheng Jiamin, Li Yinyin, Wang Xiaohui, Dong Zheng, Chen Yan, Zhang Rui, Huang Jiagan, Jin Xueyuan, Yao Jianfei, Ge Aifang, Song Lele, Lu Yinying, Zeng Zh |
Evaluation of CCL5 -403 G>A and CCR5 ?32 gene polymorphisms in patients with breast cancer. Cancer biomarkers : section A of Disease markers 2014 14 (5): 343-51. Eskandari-Nasab Ebrahim, Hashemi Mohammad, Ebrahimi Mahboubeh, Amininia Shadi, Bahari Gholamreza, Mashhadi Mohammad-Ali, Taheri Mohs |
CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma. Medical oncology (Northwood, London, England) 2012 Dec 29 (4): 2771-9. Tsai Hsiu-Ting, Yang Shun-Fa, Chen Dar-Ren, Chan Szu-E |
Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis. World journal of gastroenterology : WJG 2008 Feb 14 (5): 713-9. Nahon Pierre, Sutton Angela, Rufat Pierre, Simon Chantal, Trinchet Jean-Claude, Gattegno Liliane, Beaugrand Michel, Charnaux Nathal |
Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study. European journal of gastroenterology & hepatology 2007 May 19 (5): 425-31. Nahon Pierre, Sutton Angela, Rufat Pierre, Faisant Charles, Simon Chantal, Barget Nathalie, Trinchet Jean-Claude, Beaugrand Michel, Gattegno Liliane, Charnaux Nathal |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 07, 2023
- Content source: